Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Probiotics Antimicrob Proteins. 2013 Jan 13;5(1):26–35. doi: 10.1007/s12602-012-9123-x

Figure 2. Subtilosin inhibits HSV-1 replication in a dose-dependent manner.

Figure 2

Vero cells infected with HSV-1 tk+ (m.o.i.= 1) were incubated with different concentrations of subtilosin for 24 h. Then, supernatants were harvested and cell free virus yields were determined by a plaque assay. Values are means ± SD of the log reduction in HSV-1 titers for each concentration compared to no drug. Data are from three independent experiments, where each titration was carried out in duplicate. Percentages of inhibition of the different treatments are expressed in each column.